Matej Pičulin

Matej Pičulin

Auto-generated profile, based on publicly available information

Matej Pičulin

University of Ljubljana, Faculty of Computer and Information Science, Večna pot 113, Ljubljana, Slovenia

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2022 in JMIR Medical Informatics
Verified
Journal Article
Open access
MPMatej Pičulin
Matej Pičulin
TSTim Smole
Tim Smole
BŽBojan Žunkovič
Bojan Žunkovič
EKEnja Kokalj
Enja Kokalj
MRMarko Robnik-Šikonja
Marko Robnik-Šikonja
ZBZoran Bosnić
Zoran Bosnić
Background: Cardiovascular disorders in general are responsible for 30% of deaths worldwide. Among them, hypertrophic cardiomyopathy (HCM) is a genetic cardiac disease that is present in about 1 of 500 young adults and can cause sudden cardiac death (SCD). Objective: Although the current state-of-the-art methods model the risk of SCD for patients, to the best of our knowledge, no methods are available for modeling the patient's clinical status up to 10 years ahead. In this paper, we propose a novel machine learning (ML)-based tool for predicting disease progression for patients diagnosed with HCM in terms of adverse remodeling of the heart during a 10-year period. Methods: The method consisted of 6 predictive regression models that independently predict future values of 6 clinical characteristics: left atrial size, left atrial volume, left ventricular ejection fraction, New York Heart Association functional classification, left ventricular internal diastolic diameter, and left ventricular internal systolic diameter. We supplemented each prediction with the explanation that is generated using the Shapley additive explanation method. Results: The final experiments showed that predictive error is lower on 5 of the 6 constructed models in comparison to experts (on average, by 0.34) or a consortium of experts (on average, by 0.22). The experiments revealed that semisupervised learning and the artificial data from virtual patients help improve predictive accuracies. The best-performing random forest model improved R2 from 0.3 to 0.6. Conclusions: By engaging medical experts to provide interpretation and validation of the results, we determined the models' favorable performance compared to the performance of experts for 5 of 6 targets.

27 May 2023 in Heliyon
Verified
Journal Article
Open access
Bogdan MilicevicBogdan Milicevic
Bogdan Milicevic
MMMiljan Milošević
Miljan Milošević
Vladimir SimicVladimir Simic
Vladimir Simic
Andrej PrevedenAndrej Preveden
Andrej Preveden
Lazar VelickiLazar Velicki
Lazar Velicki
Nenad FilipovicNenad Filipovic
Nenad Filipovic
Predicting the long-term expansion and remodeling of the left ventricle in patients is challenging task but it has the potential to be clinically very useful. In our study, we present machine learning models based on random forests, gradient boosting, and neural networks, used to track cardiac hypertrophy. We collected data from multiple patients, and then the model was trained using the patient's medical history and present level of cardiac health. We also demonstrate a physical-based model, using the finite element procedure to simulate the development of cardiac hypertrophy. Our models were used to forecast the evolution of hypertrophy over six years. The machine learning model and finite element model provided similar results. The finite element model is much slower, but it's more accurate compared to the machine learning model since it's based on physical laws guiding the hypertrophy process. On the other hand, the machine learning model is fast but the results can be less trustworthy in some cases. Both of our models, enable us to monitor the development of the disease. Because of its speed machine learning model is more likely to be used in clinical practice. Further improvements to our machine learning model could be achieved by collecting data from finite element simulations, adding them to the dataset, and retraining the model. This can result in a fast and more accurate model combining the advantages of physical-based and machine learning modeling.

1 November 2014 in Expert Systems with Applications
Verified
Journal Article
Closed access
MPMatej Pičulin
Matej Pičulin
MRMarko Robnik-Šikonja
Marko Robnik-Šikonja

18 May 2021 in JMIR Preprints
Verified
Preprint
Open access
MPMatej Pičulin
Matej Pičulin
TSTim Smole
Tim Smole
BŽBojan Žunkovič
Bojan Žunkovič
EKEnja Kokalj
Enja Kokalj
MRMarko Robnik-Šikonja
Marko Robnik-Šikonja
ZBZoran Bosnić
Zoran Bosnić
BACKGROUND Cardiovascular disorders in general are responsible for 30% of deaths worldwide. Among them, hypertrophic cardiomyopathy (HCM) is a genetic cardiac disease that is present in about 1 of 500 young adults and can cause sudden cardiac death (SCD). OBJECTIVE Although the current state-of-the-art methods model the risk of SCD for patients, to the best of our knowledge, no methods are available for modeling the patient's clinical status up to 10 years ahead. In this paper, we propose a novel machine learning (ML)-based tool for predicting disease progression for patients diagnosed with HCM in terms of adverse remodeling of the heart during a 10-year period. METHODS The method consisted of 6 predictive regression models that independently predict future values of 6 clinical characteristics: left atrial size, left atrial volume, left ventricular ejection fraction, New York Heart Association functional classification, left ventricular internal diastolic diameter, and left ventricular internal systolic diameter. We supplemented each prediction with the explanation that is generated using the Shapley additive explanation method. RESULTS The final experiments showed that predictive error is lower on 5 of the 6 constructed models in comparison to experts (on average, by 0.34) or a consortium of experts (on average, by 0.22). The experiments revealed that semisupervised learning and the artificial data from virtual patients help improve predictive accuracies. The best-performing random forest model improved R2 from 0.3 to 0.6. CONCLUSIONS By engaging medical experts to provide interpretation and validation of the results, we determined the models' favorable performance compared to the performance of experts for 5 of 6 targets.